About this trial
Physiological evaluation is part of the preoperative risk estimation in patients with lung cancer, and it aids in the choice of treatment. Ventilatory efficiency during exercise has emerged as a strong predictor of major postoperative complications, so far determined during a maximal cardiopulmonary exercise test. However, this test is limited by its availability and high cost, due to the requirement of high-technological equipment and advanced expertise. The current project aims to evaluate a simplified and accessible method for risk evaluation before decision on treatment in lung cancer. It builds on recent advances in technology and knowledge and combines a simple, low-intensity cycling test with measurement of ventilatory efficiency (end-tidal carbon dioxide pressure) with a handheld monitor. In a prospective, multi-center design the investigators will include patients evaluated for suspected lung cancer. The main objective is to establish threshold values for end-tidal carbon dioxide associated with low respectively high risk of major complications in patients undergoing surgery. In addition, the study aims to determine if end-tidal carbon dioxide can predict severe side-effects during neoadjuvant or curatively aiming systemic therapy. The project is closely linked to clinical practice, and the results can be easily implemented due to the simple and cost-efficient methodology. the suggested simplified approach would also allow access to physiological evaluation where more advanced methods are unavailable.
Eligibility criteria
Qualifiers
Lung Cancer Diagnosis
Age of at least 18 years
Disqualifiers
Not able to perform cycle ergometer exercise
Not able to understand spoken or written Swedish
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Linkoeping University
Lead sponsor
Region Östergötland
Collaborator
Region Skane
Collaborator
Region Kalmar län
Collaborator
Region Blekinge
Collaborator
Region Jönköping County
Collaborator